Peptide Antibiotics Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

Peptide Antibiotics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The size of the peptide antibiotics market has seen a significant expansion lately. It is set to rise from $5.25 billion in 2024 to $5.82 billion in 2025, with a compound annual growth rate (CAGR) of 10.8%. This growth during the historic period can be credited to the progress and discovery of peptide antibiotics, a surge in antibiotic resistance, an increase in the occurrence of infectious diseases, advancements in peptide synthesis technologies, and the expansion of the pharmaceutical industry.

Peptide Antibiotics Market Size Forecast: What's the Projected Valuation by 2029?
The market for peptide antibiotics is predicted to experience significant expansion in the forthcoming years, with expected growth to $8.47 billion by 2029 at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to this growth in the projected period include the accentuated focus on the creation of novel antibiotics, the rising worldwide occurrence of antibiotic-resistant infections, broadening research and development in the domain of antimicrobial peptides, and regulatory backing for new antibiotic approvals. Key trends foreseen throughout this period encompass probing natural sources for antimicrobial peptides, utilizing peptide antibiotics for animal health, focusing on peptide engineering for superior efficacy, devising combination peptide antibiotics, and incorporating artificial intelligence and machine learning into peptide antibiotic discovery.

View the full report here:
https://www.thebusinessresearchcompany.com/report/peptide-antibiotics-global-market-report

What Are the Drivers Transforming the Peptide Antibiotics Market?
The expected surge in the occurrence of multiple infectious diseases is forecasted to boost the peptide antibiotics market. These diseases are triggered by harmful microorganisms like bacteria, fungi, parasites and more. Factors such as rapid urbanization, climate alterations, escalating risks of disease outbreaks among others, have amplified the need for peptide antibiotics. These antibiotics play a crucial role in destroying the cell membranes and underpinning the antibacterial activity. For instance, the World Health Organization, a Switzerland-based intergovernmental organization, reported in May 2024, that in the American region, dengue cases had already surpassed seven million by April, a figure that's significantly higher than the 4.6 million cases reported the previous year. Thus, the escalation in the incidents of infectious diseases is fueling the growth of the peptide antibiotics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7780&type=smp

What Long-Term Trends Will Define the Future of the Peptide Antibiotics Market?
In the peptide antibiotics market, strategic collaborations have become a prevalent trend. Major players in this market are teaming up to broaden their market impact and capitalize on their combined resources. For instance, in January 2022, a partnership was formed between Berkeley Lights, an American digital cell biology firm, and Aanika Biosciences. Within this collaboration, Aanika will harness Berkeley Lights' high-capacity, functional screening service to quickly isolate and re-engineer antimicrobial peptides (AMPs) effective in killing harmful bacteria, notably the ones responsible for foodborne disease outbreaks. Also, they will use the Beacon Optofluidic Platform to pinpoint peptides toxic to bacteria and subsequently develop a unique antibacterial tag. This tag will then be incorporated into their bacterial spore-based barcoding technology to reinforce the safety of the food supply chain. Aanika Biosciences is a biotech firm based in the US.

Which Segments in the Peptide Antibiotics Market Offer the Most Profit Potential?
The peptide antibiotics market covered in this report is segmented -

1) By Type: Ribosomal Synthesized Peptide Antibiotics, Non-Ribosomal Synthesized Peptide Antibiotics
2) By Drugs: Daptomycin, Dalbavancin, Telavancin, Other Drugs
3) By Disease Outlook: Skin Infection, HABP Or VABP, Blood Stream Infection, Other Diseases
4) By Distribution Channel: Hospitals, Homecare, Specialty Clinics, Other Distribution Channels

Subsegments:
1) By Ribosomal Synthesized Peptide Antibiotics: Aminoglycosides, Macrolides, Tetracyclines, Lincosamides
2) By Non-Ribosomal Synthesized Peptide Antibiotics: Bacitracins, Vancomycin, Polymyxins, Cyclic Lipopeptides

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7780&type=smp

Which Firms Dominate the Peptide Antibiotics Market by Market Share and Revenue in 2025?
Major companies operating in the peptide antibiotics market include Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Sandoz International GmbH, Xellia APS, Johnson & Johnson Inc., AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Lupin Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Wockhardt Ltd., Zydus Lifesciences Limited, Alkem Laboratories Limited, Allecra Therapeutics GmbH, Antabio, Basilea Pharmaceutica Ltd., BioVersys AG

Which Regions Offer the Highest Growth Potential in the Peptide Antibiotics Market?
North America was the largest region in the peptide antibiotics market in 2024. The regions covered in the peptide antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7780

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.